Related Experiment Video
Updated: Nov 8, 2025

Postconditioning with Lactate-enriched Blood for Cardioprotection in ST-segment Elevation Myocardial Infarction
Published on: May 28, 2019
Deferred Stenting for Heavy Thrombus Burden During Percutaneous Coronary Intervention for ST-Elevation MI
Akshyaya Pradhan1, Monika Bhandari1, Pravesh Vishwakarma1
1Department of Cardiology, King George's Medical University Lucknow, India.
Insights
Deferred stenting after prolonged anticoagulation may reduce infarct size in select ST-elevation MI patients with large thrombus burdens. This strategy aims to mitigate slow-flow/no-reflow phenomena and improve cardiovascular outcomes.
Area of Science:
- Cardiology
- Interventional Cardiology
- Acute Coronary Syndromes
Background:
- ST-elevation MI (STEMI) often presents with significant thrombus burden.
- Primary percutaneous coronary intervention with stenting can trigger slow-flow/no-reflow, increasing periprocedural MI risk.
- Deferred stenting is explored to reduce thrombus burden and mitigate these risks.
Purpose of the Study:
- To evaluate the safety and feasibility of deferred stenting after 5 days of anticoagulation in a STEMI patient with a large thrombus.
- To review existing literature on deferred stenting strategies in STEMI.
- To propose a clinical algorithm for implementing deferred stenting.
Main Methods:
- Case report of a 45-year-old smoker with STEMI and large thrombus.
- Review of registries, trials, and meta-analyses on deferred stenting.
- Analysis of benefits and harms of the deferred stenting strategy.
Main Results:
- The case demonstrated safety and feasibility of deferred stenting post-anticoagulation.
- Literature review suggests potential benefits in properly selected patients.
- Analysis highlights the need for careful patient selection to maximize benefits and minimize harms.
Conclusions:
- Deferred stenting, particularly after prolonged anticoagulation, shows promise for reducing infarct size in selected STEMI patients.
- A tailored approach based on thrombus burden and patient factors is crucial.
- An evidence-based algorithm can guide clinical decision-making for deferred stenting.
Abstract:
Patients with ST-elevation MI (STEMI) usually have a huge thrombus burden in the infarct-related artery. Stenting may lead to high chances of the slow-flow/no-reflow phenomenon that leads to periprocedural MI and adverse cardiovascular events. Deferred stenting may be beneficial in this situation as the thrombus burden will reduce, mitigating the slow-flow/no-reflow phenomenon. However, routine deferral of stenting in patients with STEMI has not been found to be beneficial, but when the patient is properly selected, deferred stenting has the potential for reducing the final infarct size. The authors report the safety and feasibility of deferred stenting after 5 days of prolonged anticoagulation in a 45-year-old smoker with STEMI who had a large thrombus load shown on an angiogram. They review the registries, trials and meta-analyses on deferred stenting in the literature and analyse the benefits and harms of the strategy. They also propose an algorithm for applying a strategy for deferred stenting in clinical practice based on the available data.
Related Concept Videos
Peripheral Artery Disease III: Interprofessional Care
Acute Coronary Syndrome I: Introduction
Acute Coronary Syndrome IV: Interprofessional Care
Coronary Artery Disease V: Interprofessional Care
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
Venous Thrombosis III: Interprofessional Care

